FIDA has developed into one of the largest manufacturers of retractable leashes worldwide, with successful sales throughout Europe, America and Asia.
26 years of experience
The Best-Run Technology Co., Ltd. (FIDA) is a specialized producer of retractable leashes founded in 1991. Over the last 26 years, FIDA has acquired more than 100 patents. The number one brand in retractable leashes worldwide, FIDA has set up offices in the U.S., Europe and Japan, and an R&D centre, a sales centre and a manufacturing centre in China.
Advanced brand concept
FIDA believes that sport is the source of pet health, which is why it has always stuck to the philosophy “Dog, the king of sports”. FIDA is devoted to combining pet health and human needs, and the result is a highly praised concept for pet sports.
Constantly innovating, FIDA has created a new world in the field of pet supplies. Detailed market surveys, ergonomic analyses and countless tests have led to the UFO series leashes that are more comfortable to operate and with improved user experience.
Quality assurance
FIDA always insists on knowledge innovation, so it is no surprise that its production processes are patented – from design, mould development, injection moulding, and assembly right through to sales. And in order to improve customer service, FIDA has set up a service centre in Europe. The company also has a state-of-the-art testing centre. Machining and assembling precision components is fully automated, resulting in products that are safe, easy to use, and comfortable.
FIDA believes that only the highest quality is fit for the market, and that a dynamic company like FIDA should constantly innovate. Excellent quality results in a good user experience, which users will share with each other, thus building the reputation of the company. FIDA is willing to work together with all those who are committed to creating a global kingdom of pet sport.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.